List of Publication
Dr. Abdul Wadood
1) In silico identification of novel inhibitors against Plasmodium falciparum dihydrooratate dehydrogenase. Abdul Wadood and
Zaheer-ul-Haq. J. Mol. Graph. Model. 2013, 40, 40-47.
Impact Factor 2.033
2) Interaction and inhibition of dengue envelope glycoprotein with mammalian receptor DC-sign, an in-silico approach. Masaud
Shah, Abdul Wadood, Ziaur Rahman and Tayyab Hussain. PLoS One. 2013, 9, 1-10.
Impact Factor 4.411
3) Molecular docking study of P4-benzoxaborole-substituted ligands as inhibitors of HCV NS3/4A protease. Abdul Wadood,
Muhammad Riaz, Syed Babar Jamal, Masaud Shah and Muhammad Arif Lodhi. Bioinformation. 2013, 9, 309-314.
Impact Factor 1.153
4) Identification of novel interleukin-2 inhibitors through computational approaches. Sobia Ahsan Halim, Omer Mohammad
Abdalla, M. Ahmed Mesaik, Abdul Wadood, Zaheer-Ulhaq and Maria Kontoyianni. Mol. Diver. 2013, 7, 345-355.
Impact Factor 3.153
5) Urease inhibitory activity of ursane type sulfated saponins from the aerial parts of Zygophyllum fabago linn. Saleha Suleman
Khan, Ajmal Khan, Afsar Khan, Abdul Wadood, Umar Farooq, Amir Ahmed, Aqib Zahoor, Viqar Uddin Ahmad, Bilge
Sener, Nurgum Erdemoglu. Phytomedicine. 2013. Accepted
Impact Factor 2.972
6) Homology modeling and molecular dynamic study of Candida albicans heat shock protein 21, a potential target protein for
antifungal drug development. Abdul Wadood, Nasir Ahmad, Muhammad Riaz, Sulaiman Shams and Ayaz Ahmed. Int. J. Sci.
2013. Accepted
2.114
7) Structure based virtual screening-driven identification of monastrol as a potent urease inhibitor. Umer Rashid, Iram Batool,
Abdul Wadood, Ajmal Khan, Zaheer ul-Haq, M. I. Choudhary and Farzana Latif Ansari. J. Mol. Graph. Model. 2013, 43,
47-57,
Impact Factor 2.033
8) Three-dimensional quantitative structure-activity relationship (CoMSIA) analysis of biscoumerine analogues as urease inhibitors.
Muhammad Arif Lodhi, Zaheer-ul-Haq, Abdul Wadood, Sajid Iqbal, Khalid Mohammad Khan, Atta-ur-Rahman and
Muhammad Iqbal Choudhary. Med. Chem. Res. 2013, 22, 498-504
Impact Factor 1.271
9) Pharmacological evaluation, molecular docking and dynamics simulation studies of salicyl alcohol nitrogen containing derivatives.
Gowhar Ali, Fazal Subhan, Abdul Wadood, Ajmal Khan, Nasir Ullah, Nazar Ul Islam and Ikhtiar Khan. Afric. J. Pharm.
Pharmaco. 2013. Accepted
Impact Factor 0.839
10) Prevalence of Hepatitis C in Shahbaz Ghari, District Mardan, Pakistan. Sahib Gul Afridi, Suleman Shams, Abdul Nasir,
Muhammad Junaid, Ashfaq ur Rahman, Muhammad Naeem, Najam Saqib and Abdul Wadood. Life Sci. J. 2013.
Accepted
11) Frequencey distribution of ABO, Rh Blood Group among the Students of Abdul Wali Khan University Mardan, Pakistan.
Suleman Shams, Sahib Gul Afridi, Abdul Wadood, Marukh Iqbal, Mehwish Munir, Umaia Shams, Madiha Khan and Shumaila
Yousaf. IJAVMS. 2013.
Accepted
12) Structure and Dynamics of Alpha-glusidase through molecular dynamics simulation studies. Syed Sikandar Azam, Reaz Uddin,
Abdul Wadood. J. Mol. Liquid. 2012, 174, 58-62.
Impact Factor 1.580
13) A novel pharmacophore model to identify leads for simultaneous inhibition of anti-coagulation and anti-inflammatory activities of
snake venom phospholipase A2. Abdul Wadood, Syed Abid Ali, Rabbia Sattar, Muhammad Arif Lodhi and Zaheer-ul-Haq.
Chem. Biol. Drug Des. 2012, 87, 431-441.
Impact Factor 2.527
14) Molecular modeling-based antioxidant arylidene barbiturates as urease inhibitors. Khalid M. Khan, Muhammad Ali, Abdul
Wadood, Zaheer-ul-Haq, Monin Khan, Muhammad Arif Lodhi, Shahnaz Perveen, Muhammad Iqbal Choudhary and Wolfgang
Voelter. J. Mol. Graph. Model. 2011, 30, 153-156.
Impact Factor 2.033
15) Docking and 3D-QSAR Modeling of Cyclin-Dependent Kinase 5/p25 Inhibitors. Zaheer-ul-Haq, Reaz Uddin, Lam Kok Wai,
Abdul Wadood, Nordin Haji Lajis. J. Mol. Model. 2011, 17, 1149-1161.
Impact Factor 1.871
16) Identification of Novel Urease Inhibitors by High-Throughput Virtual and in Vitro Screening. Obaid-ur-Rahman Abid, Tariq M.
Babar, Farukh I. Ali, Shahzad Ahmed, Abdul Wadood, Nasim H. Rama, Zaheer-ul-Haq, Reaz Uddin, Ajmal Khan,
Mohammd I. Choudhary. ACS Med. Chem. Letts. 2010, 1, 145-149.
Impact Factor: 3.355
17) Identification of Potent Urease Inhibitors via Ligand- and Structure-based Virtual Screening and in vitro Assay. Khalid M.
Khan, Abdul Wadood, Mohammad Ali, Zia Ullah, Zaheer-ul-Haq, Mohammad A. Lodhi, Momin Khan, Shahnaz parveen,
Mohammad I. Choudhary. J. Mol. Graph. Model. 2010. 28, 792-798.
Impact Factor 2.033
18) Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives. Imtiaz Khan,
Sajid Ali, Shahid Hameed, Nasim Hasan Rama, Muhammad Tahir Hussain, Abdul Wadood, Reaz Uddin, Zaheer Ul-Haq,
Ajmal Khan, Sajjad Ali, M. Iqbal Choudhary. Eur. J. Med. Chem. 2010, 45, 5200-5207.
Impact Factor 3.193
19) Prediction of Binding Affinities for Hydroxamic Acid Derivatives as Urease Inhibitors by Molecular Docking and 3D-QSAR.
Zaheer-ul-Haq, Abdul Wadood. Lett. Drug. Des. Discov. 2009, 6, 93-100.
Impact Factor 0.805
20) In Silico Studies of Urease Inhibitors to Explore Ligand-Enzyme Interaction. Farzana L. Ansari, Abdul Wadood, Ahsan Ullah,
Fatima Iftikhar, Zaheer-ul-Haq. J. Enz. Inhib. Med. Chem. 2009, 24 (1) 151-156.
Impact Factor 1.496
21) CoMFA and CoMSIA 3D-QSAR Analysis on Hydroxamic Acid Derivatives as Urease. Zaheer-ul-Haq, Abdul Wadood,
Reaz Uddin. J. Enz. Inhib. Med. Chem. 2009, 24 (1) 272-278.
Impact Factor 1.496
Projects
Completed: 01
In progress: 02
Submitted: 02